OpenLobby.EU
Explore

European Society of Cardiology

ESC

The European Society of Cardiology works to reduce the burden of cardiovascular disease across Europe.

Lobbying Activity

Meeting with Flora Giorgio (Head of Unit Health and Food Safety) and Biomedical Alliance in Europe

12 Dec 2025 · Exchange on matters related to the MDCG CIEPSE WG and on the upcoming conference on medical devices

Meeting with Piotr Serafin (Commissioner)

4 Dec 2025 · EU Cardiovascular Health Plan

Meeting with Sebastian Everding (Member of the European Parliament)

19 Nov 2025 · EU Cardiovascular Disease Strategy

Response to EU’s next long-term budget (MFF) – EU funding for competitiveness

7 Nov 2025

Please find attached the European Society of Cardiology (ESC)s response and feedback on the proposal for the Regulation establishing Horizon Europe for the 20282034 period.
Read full response

Meeting with Pascal Arimont (Member of the European Parliament)

30 Oct 2025 · Cardiovascular Health in the European Healthcare Sector

Meeting with Ekaterina Zaharieva (Commissioner) and

27 Oct 2025 · Cardiovascular research

Meeting with Tomislav Sokol (Member of the European Parliament, Rapporteur) and Adamed Pharma S.A.

16 Oct 2025 · Health Policy

ESC urges centralized agency to solve EU medical device shortages

6 Oct 2025
Topic — The European Commission is revising regulations to ensure medical device availability and safety.
Message — The ESC calls for a single EU agency to coordinate regulatory assessments and clinical evidence. They recommend creating priority pathways for breakthrough technologies and involving healthcare professionals throughout the process.123
Why — Centralization would improve cardiac patient care by ensuring a steady supply of equipment.45
Impact — National agencies lose power as regulatory authority shifts to a single coordinating pinpoint.67
Read full response

Meeting with Wopke Hoekstra (Commissioner) and

30 Sept 2025 · Public health and tobacco matetrs

Meeting with Olivér Várhelyi (Commissioner), Wopke Hoekstra (Commissioner) and

30 Sept 2025 · Public health and tobacco matters

Meeting with Margarita De La Pisa Carrión (Member of the European Parliament)

18 Sept 2025 · Cardiovascular health plan

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

16 Sept 2025 · Pharmaceutical products

ESC Urges EU Action Plan to Combat Cardiovascular Disease

12 Sept 2025
Topic — The consultation seeks feedback on establishing the first-ever European Cardiovascular Health Plan.
Message — The ESC calls for a far-reaching plan with a meaningful budget in the financial framework. They advocate for a European Heart Data Hub and specialized centers to leverage health data. They recommend EU-wide screening and a Council Recommendation on a cardiometabolic health check.123
Why — This would provide society members with increased funding and better access to health data.45
Impact — Fossil fuel companies would lose support through the proposed phasing out of industry subsidies.6
Read full response

Response to Gender Equality Strategy 2026-2030

11 Aug 2025

Please find attached a statement from the European Society of Cardiology (ESC) outlining key priorities and recommendations for improving cardiovascular health in women and addressing existing inequalities, in view of the upcoming Gender Equality Strategy 2026-2030. Thank you for your attention.
Read full response

Meeting with Olivér Várhelyi (Commissioner) and

10 Jun 2025 · Preparation for the upcoming EU Cardiovascular Action Plan

Meeting with Maria Walsh (Member of the European Parliament)

13 Mar 2025 · Cardiology

Meeting with Stine Bosse (Member of the European Parliament)

5 Feb 2025 · European health policy

Meeting with Pascal Arimont (Member of the European Parliament)

27 Jan 2025 · Actions taken on cardiovascular diseases (CVD)

Meeting with Estelle Ceulemans (Member of the European Parliament)

16 Jan 2025 · Dossier SANT à venir

Meeting with Elena Nevado Del Campo (Member of the European Parliament)

15 Jan 2025 · Cardiovascular health

Meeting with Victor Negrescu (Member of the European Parliament)

9 Jan 2025 · Cardiovascular Health Plan

Meeting with Vlad Vasile-Voiculescu (Member of the European Parliament) and Novo Nordisk A/S

11 Dec 2024 · Introductory Meeting

Meeting with Kristian Vigenin (Member of the European Parliament)

20 Nov 2024 · EU plan for cardiovascular diseases

Meeting with Aurelijus Veryga (Member of the European Parliament)

13 Nov 2024 · Promoting cardiovascular health as a national and EU priority

Meeting with Nicolás González Casares (Member of the European Parliament)

16 Oct 2024 · Non-communicable diseases

Meeting with Lukas Mandl (Member of the European Parliament)

15 Oct 2024 · EU health policy / Cardiovascular disease

Meeting with András Tivadar Kulja (Member of the European Parliament)

1 Oct 2024 · Cardiovascular health

Meeting with Maria Walsh (Member of the European Parliament)

25 Sept 2024 · European Society of Cardiology

Meeting with Vytenis Povilas Andriukaitis (Member of the European Parliament)

10 Sept 2024 · EU health policy

Meeting with Tilly Metz (Member of the European Parliament)

9 Sept 2024 · Cardiovascular health

Meeting with Maria Angela Danzì (Member of the European Parliament)

27 Feb 2024 · Malattie cardiovascolari

Meeting with Tilly Metz (Member of the European Parliament, Shadow rapporteur) and European Patients' Forum (EPF)

23 Feb 2024 · Pharmaceutical legislation

Meeting with Joanna Kopcińska (Member of the European Parliament)

13 Dec 2023 · Presentation of the exhibition "Vote Cardiovascular Health 2024"

Meeting with Karol Karski (Member of the European Parliament)

13 Dec 2023 · Presentation of the exhibition "Vote Cardiovascular Health 2024"

Meeting with Pascal Arimont (Member of the European Parliament) and Novartis International AG

13 Dec 2023 · Prevention and non-communicable diseases - cardiovascular health checks

Meeting with Anna Fotyga (Member of the European Parliament)

13 Dec 2023 · Presentation of the exhibition "Vote Cardiovascular Health 2024"

Meeting with Ryszard Antoni Legutko (Member of the European Parliament)

13 Dec 2023 · Presentation of the exhibition "Vote Cardiovascular Health 2024"

Meeting with Katarína Roth Neveďalová (Member of the European Parliament)

12 Dec 2023 · Cardiovascular diseases

Meeting with Cristian-Silviu Buşoi (Member of the European Parliament)

12 Dec 2023 · interview during the exhibition Vote Cardiovascular Health 2024

Meeting with Brando Benifei (Member of the European Parliament)

12 Dec 2023 · Discussion on cardiovascular diseases

Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur) and AbbVie and

25 Oct 2023 · Pharmaceutical legislation

Meeting with Tiemo Wölken (Member of the European Parliament)

23 Oct 2023 · Pharma Revision - DIrective (staff level)

Meeting with Tilly Metz (Member of the European Parliament, Shadow rapporteur)

26 Sept 2023 · EHDS

Meeting with Maria da Graça Carvalho (Member of the European Parliament)

13 Jul 2023 · MEP Heart group activities and planned events, health policies

Meeting with Elisabetta De Blasis (Member of the European Parliament, Shadow rapporteur)

27 Jun 2023 · European Health Data Space, Reform of the pharmaceutical legislation

Meeting with Tilly Metz (Member of the European Parliament, Shadow rapporteur)

22 Feb 2023 · European Health Data Space

Meeting with Dolors Montserrat (Member of the European Parliament, Rapporteur) and European Cancer Organisation

12 Jan 2023 · Lessons learned on impact of COVID-19 pandemic

Meeting with Maria da Graça Carvalho (Member of the European Parliament)

7 Dec 2022 · Mep Heart Group

Meeting with Ciarán Cuffe (Member of the European Parliament)

6 Dec 2022 · Ambient Air Quality

Meeting with Axel Voss (Member of the European Parliament)

25 Oct 2022 · AI in Medicine

Meeting with Irène Tolleret (Member of the European Parliament)

19 Oct 2022 · Disparité dans les zones rurales

Cardiology society demands clinical expert role in health data space

28 Jul 2022
Topic — A proposal to create a unified European framework for sharing health data.
Message — The ESC calls for medical societies to help define technical data standards. They want to avoid extra paperwork for doctors and use existing heart disease registries. The group also requests financial support for non-profit organizations to manage data systems.123
Why — Using their existing registry standards would reduce their compliance costs and administrative burden.4
Impact — Public sector bodies would lose their exclusive legal priority for accessing electronic data.5
Read full response

Meeting with Stella Kyriakides (Commissioner) and European Heart Network

25 Jun 2020 · The MEP Heart Group also participated. The Associations presented their work and the discussion focused on the impact of COVID19 on patients with cardiovascular diseases and F2F and its link to healthy diets and benefits for cardiovascular patients.

Meeting with Mariya Gabriel (Commissioner)

3 Dec 2019 · Cardiovascular diseases and Horizon Europe Programme

Meeting with Anne Bucher (Director-General Health and Food Safety)

17 Jul 2019 · cardiovascular disease challenge, shaping Horizon Europe priorities

Response to European Electronic Health Record (EHR) Exchange Format

20 Dec 2018

The European Society of Cardiology (ESC) welcomes the European Commission’s initiative aiming at the establishment of a format for a European Electronic Health Record (EHR) Exchange. The ESC strongly believes that cross-border interoperability and access to health records are a fundamental pre-requisite for quality patient care across the EU. Beyond the obvious benefits for individual patients’, the establishment of EHR Exchange also has immense potential to facilitate EU-wide healthcare planning through centralised data collection. Indeed, patient registries are fundamental to record management and outcomes of a disease, monitoring quality of care and are a fundamental resource for medical research (for instance towards the identification of unmet needs, the analysis of advanced analytics and the performance real-world effectiveness studies). In order for EHR exchange to be truly useful, an underlying governing premise is thus for data sets to be comprehensive and representative, encompassing the different variables required for clinical audit, service planning and epidemiological research. In addition, harmonised EU data standards and definitions of the variables must be in place to ensure comparability and transferability of data in respect of patient confidentiality and data protection. However, security and patient privacy are fundamental features for a cross-border electronic eHealth exchange system. Access to patients’ health records has to ensure that patient confidentiality and data protection rules are followed and well considered In conclusion, the European Society of Cardiology invites EU policymakers to ensure that standardisation of health data and registries are addressed as a matter of priority by the new legislation, and will be pleased to provide its expert advice for the construction of a truly effective and forward-looking system for cross-border healthcare.
Read full response

Response to Establishing a legal limit for the industrial trans fats content in foods

30 Oct 2018

The European Society of Cardiology welcomes the European Commission’s draft Regulation amending Annex III to Regulation (EC) No 1925/2006 aimed at restricting on the level of industrial trans fatty acids in food. The European Society of Cardiology believes that setting a maximum limit of trans fats of 2 grams per 100 grams in foods can greatly minimise associated risks and reduce the occurrence of heart disease - Europe’s number one killer. The European Society of Cardiology trusts that the introduction of a legislative limit can maximise impact of results and reduce effectively trans-fat intake in all population groups. Legislative limits for TFAs have already been implemented in some European Member States for many years now with successful results. (Denmark) Considering the significant health benefits that this measure can offer to the European population, the European Society of Cardiology regrets that the draft regulation proposes a transitional period until 1st April 2021.
Read full response

Meeting with Vytenis Andriukaitis (Commissioner) and

22 May 2018 · Medical registries, clinical research, actions on non communicable diseases

Meeting with Vytenis Andriukaitis (Commissioner) and

3 May 2018 · HTA

Meeting with Vytenis Andriukaitis (Commissioner) and

28 Sept 2015 · World Heart Day Campaign ‘Environment & the Heart’

Meeting with Vytenis Andriukaitis (Commissioner) and

28 Jan 2015 · Action on Cardiovascular Diseases inlcuding Indicators. Registries, E-Health Solutions and Bridging Inequalities

Meeting with Carlos Moedas (Commissioner), Carlos Moedas (Commissioner)

26 Jan 2015 · Biomedical Research